Acknowledgements and Funding We thank Arturo Valle Mendiola for help with immunohistochemical analysis as well as to Eduardo Arreola Martínez and Itzel Moreno Martínez for figure preparation. This work was supported by grants from the Universidad Nacional Autónoma de México (PAPIIT) IN221309 and the Consejo Nacional de Ciencia y Tecnología (CONACYT) 41793-M. References 1. Burgess SJ, Maasho K, Masilamani M, Narayanan S, Borrego F, Coligan JD: The NKG2D receptor: immunobiology and clinical implications. Immunol Res 2008, 40:18–34.PubMedCrossRef 2. Jonjic’ S, Polic’ B, Krmpotic’ : The role of NKG2D in immunoevasion by tumors and
viruses. Eur C646 cost J Immunol 2008, 38:2927–68.CrossRef 3. Wrobel P, Shojaei B, Schittek F, Gieseler B,
Wollenberg H, Kalthoff D, Kabelitz D, Wesch D: Lysis of a broad range of epithelial tumour cells by human gammadelta T cells: involvement of NKG2D ligands and T-cell receptor-versus NKG2D-dependent recognition. Scand J Immunol 2007, 66:320–28.PubMedCrossRef 4. Saez-Borderias A, Guma M, Angulo A, Vellosillo B, Pende D, Lopez-Botet M: Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. Eur J Immunol 2006, 36:3198–06.PubMedCrossRef 5. Mendoza-Rincon JF: Human MICA and MICB genes: their biological function and relevance to infection and cancer. In Advances in Cancer Research at UNAM. Edited by: Mas-Oliva J, Ninomiya-Alarcon J, Garcia-Carranca A. Mexico City; Manual Moderno; 2007:127–135. 6. Paschen A, Sucker A, Hill B, Moll I, Zapatka M, Nguyen Rutecarpine XD, Sim GC, Gutmann I, Hassel J, Becker JC, Steinle A, Schadendorf D, Ugurel S: Differential clinical significance of individual NKG2D NSC 683864 mouse ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B. Clin Cancer Res 2009, 15:5208–15.PubMedCrossRef 7. Unni AM, Bondar T, Medzhitov R: Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance. Proc Natl Acad Sci USA 2008, 105:1686–91.PubMedCrossRef 8. Kato NJ, Tanaka J, Sugita T, Toubai Y, Miura M, Ibata Y, Syono Y, Ota S, Kondo T, Asaka M, Imamura M: Regulation of the expression of MHC class I-related chain
A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells. Leukemia 2007, 21:2103–08.PubMedCrossRef 9. Chalupny NJ, Rein-Weston A, Dosch S, Cosman D: Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem Biophys Res Commun 2006, 346:175–81.PubMedCrossRef 10. Tosh K, Ravikumar M, Bell JT, GSK458 in vitro Meisner S, Hill AV, Pitchappan R: Variation in MICA and MICB genes and enhanced susceptibility to paucibacillary leprosy in South India. Hum Mol Genet 2006, 15:2880–87.PubMedCrossRef 11. Santoni A, Zingoni A, Cerboni C, Gismongi A: Natural killer (NK) cells from killers to regulators: distinct features between peripheral blood and decidual NK cells.